Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Racial and ethnic differences in adjuvant hormonal therapy use.

Journal of women's health (2002) - 1 Sept 2012

Livaudais Jennifer C, Li Christopher, John Esther M, Terry Mary Beth, Daly Mary, Buys Saundra S, Habel Laurel, Thompson Beti, Yanez N David, Coronado Gloria D

Abstract excerpt

BACKGROUND: In the United States, 5-year breast cancer survival is highest among Asian American women, followed by non-Hispanic white, Hispanic, and African American women. Breast cancer treatment disparities may play a role. We examined racial/ethnic differences in adjuvant hormonal therapy use among women aged 18-64 years, diagnosed with hormone receptor-positive breast cancer, using data collected by the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to California

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Health Status Disparities

Share to Healthcare Disparities

Share to Registries

Share to Self Report

Share to Socioeconomic Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 22731764
DOI: 10.1089/jwh.2011.3254
PMCID: PMC3430474

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Racial and ethnic differences in adjuvant hormonal therapy use.PMID 22731764Read ↗

Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.Semantic proximity Read ↗

Breast Cancer in Latinas: Gene Expression, Differential Response to Treatments, and Differential Toxicities in Latinas Compared with Other Population GroupsSemantic proximity Read ↗

Age-related Differences in Breast Cancer Mortality according to Race/Ethnicity, Insurance, and Socioeconomic StatusSemantic proximity Read ↗

Social determinants of health and use of neoadjuvant chemotherapy and germline genetic testing in patients with early stage triple negative breast cancer (TNBC) in the community oncology settingSemantic proximity Read ↗

Social determinants of health and use of neoadjuvant chemotherapy and germline genetic testing in patients with early stage triple negative breast cancer (TNBC) in the community oncology settingSemantic proximity Read ↗

Trends in Breast Cancer Mortality Among Elderly Males in the United States (1999–2020): A CDC WONDER AnalysisSemantic proximity Read ↗

Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer.Semantic proximity Read ↗

Patterns of 21-gene assay testing and chemotherapy use in black and white breast cancer patients.Semantic proximity Read ↗

Ethnic Disparities in Breast Cancer Patterns in Brazil: Examining Findings from Population-Based RegistriesSemantic proximity Read ↗

Differences in estrogen receptor subtype according to family history of breast cancer among Hispanic, but not non-Hispanic White women.Semantic proximity Read ↗

Parity, Lactation, and Breast Cancer Subtypes in African American Women: Results from the AMBER ConsortiumSemantic proximity Read ↗

Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.